Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-028107
Filing Date
2020-10-13
Accepted
2020-10-13 21:34:34
Documents
2
Period of Report
2020-10-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2810
2 EX-24 DOCUMENT attachment1.htm EX-24 4726
  Complete submission text file 0000899243-20-028107.txt   9112
Mailing Address C/O VITAE PHARMACEUTICLS, INC. 502 WEST OFFICE CENTER DRIVE FORT WASHINGTON PA 19034
Business Address
Bernstein Karen (Reporting) CIK: 0001654055 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39615 | Film No.: 201237913

Mailing Address C/O ARCH VENTURE PARTNERS 999 THIRD AVENUE, SUITE 3400 SEATTLE WA 98104
Business Address C/O ARCH VENTURE PARTNERS 999 THIRD AVENUE, SUITE 3400 SEATTLE WA 98104 857-400-4222
Codiak BioSciences, Inc. (Issuer) CIK: 0001659352 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)